The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: An agent-based simulation for California

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Liu, Fengchen ^a   Enanoria, Wayne T A ^b   Zipprich, Jennifer ^c   Blumberg, Seth ^a   Harriman, Kathleen ^c   Ackley, Sarah F ^a   Wheaton, William D ^d   Allpress, Justine L ^d   Porco, Travis C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; DISEASE PREDISPOSITION; EPIDEMICS; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNIZATION; MALE; MEASLES; MIDDLE AGED; PUBLIC HEALTH; SOCIOECONOMICS; THEORETICAL MODEL; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CALIFORNIA; CHILD; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; EPIDEMICS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; MEASLES; MEASLES VACCINE; MIDDLE AGED; MODELS, THEORETICAL; PUBLIC HEALTH; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84929993440     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1766-6     Document Type: Article

References (62)

1. Strebel PM, Papania MJ, Halsey NA. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Philadelphia: Saunders; 2004. p. 389-440.
2. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis. 2004;189 Suppl 1:S43-7.
3. Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States. J Infect Dis. 2004;189 Suppl 1:S1-3.
4. Parker AA, Staggs W, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med. 2006;355(5):447-55.
5. Centers for Disease Control and Prevention. Notes from the field: measles outbreak among members of a religious community - Brooklyn, New York, March-June 2013. MMWR Morb Mortal Wkly Rep. 2013;62(36):752-3.
6. Centers for Disease Control and Prevention. Measles outbreak-Southwestern Utah, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(33):766-9.
7. May T, Silverman RD. 'Clustering of exemptions' as a collective action threat to herd immunity. Vaccine. 2003;21(11-12):1048-51.
8. McBryde ES. Network structure can play a role in vaccination thresholds and herd immunity: a simulation using a network mathematical model. Clin Infect Dis. 2009;48(5):685-6. author reply 686.
9. Keeling MJ, Eames KTD. Networks and epidemic models. J R Soc Interface. 2005;2(4):295-307.
10. Ball F, Sirl D, Trapman P. Analysis of a stochastic SIR epidemic on a random network incorporating household structure. Math Biosci. 2010;224(2):53-73.
11. Goldstein E, Paur K, Fraser C, Kenah E, Wallinga J, Lipsitch M. Reproductive numbers, epidemic spread and control in a community of households. Math Biosci. 2009;221(1):11-25.
12. Bansal S, Grenfell BT, Meyers LA. When individual behaviour matters: homogeneous and network models in epidemiology. J R Soc Interface. 2007;4(16):879-91.
13. Newman MEJ. Properties of highly clustered networks. Phys Rev E Stat Nonlin Soft Matter Phys. 2003;68(2 Pt 2):026121.
14. Grefenstette J, Brown S, DePasse J, Galloway D, Lee B, Weng Y-T, et al. FRED user's guide. Version 24 January 2013. University of Pittsburgh, Carnegie-Mellon University, Pittsburgh Supercomputing Center and RTI International. 2013. http://fred.publichealth.pitt.edu/downloads/documentation/pdf/FRED-UserGuide.pdf.
15. Grefenstette JJ, Brown ST, Rosenfeld R, Depasse J, Stone NT, Cooley PC, et al. FRED (A Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations. BMC Public Health. 2013;13:940.
16. Wheaton W. U.S. synthetic population 2010 version 1.0: quick start guide. RTI International. 2014. http://www.epimodels.org/10-Midas-Docs/SynthPop/2010-synth-pop-ver1-quickstart.pdf.
17. Kutty P, Rota J, Bellini W, Redd SB. In: Roush SW, McIntyre L, Baldy LM, editors. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2013. p. 1-21. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.pdf.
18. Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. New Jersey: Princeton University Press; 2008.
19. Sartwell PE. The distribution of incubation periods of infectious disease. Am J Epidemiol 1995. 1949;141(5):386-94. discussion 385.
20. Sartwell PE. The distribution of incubation periods of infectious disease. Am J Hyg. 1950;51(3):310-8.
21. Simpson REH. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet. 1952;260(6734):549-54.
22. Simpson REH. The period of transmission in certain epidemic diseases; an observational method for its discovery. Lancet. 1948;2(6533):755-60.
23. Nishiura H, Yan P, Sleeman CK, Mode CJ. Estimating the transmission potential of supercritical processes based on the final size distribution of minor outbreaks. J Theor Biol. 2012;294:48-55.
24. Goodall EW. Incubation period of measles. Brit Med J. 1931;1:73-4.
25. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9:291-300.
26. Anderson RM, May RM. Directly transmitted infections diseases: control by vaccination. Science. 1982;215(4536):1053-60.
27. Katz SL. In: Gershon AA, Hotez PJ, Katz SL, editors. Infectious diseases of children. 11th ed. Philadelphia: Mosby; 2004. p. 353-71.
28. Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. IMA J Math App Med Biol. 1984;1:169-91.
29. Yip FY, Papania MJ, Redd SB. Measles outbreak epidemiology in the United States, 1993-2001. J Infect Dis. 2004;189 Suppl 1:S54-60.
30. Centers for Disease Control and Prevention. In: Atkinson W, Wolfe S, Hamborsky J, editors. Epidemiology and prevention of vaccine-preventable diseases. 12th edition, second printing. Washington DC: Public Health Foundation; 2012. p. 173-92.
31. Salathé M, Bonhoeffer S. The effect of opinion clustering on disease outbreaks. J R Soc Interface. 2008;5(29):1505-8.
32. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(36):733.
33. California Department of Public Health. Vaccine-preventable diseases and immunization coverage in California, 2001-2006. Center for Infectious Diseases, Division of Communicable Disease Control, Immunization Branch. 2006. http://www.cdph.ca.gov/programs/immunize/Pages/VaccinePreventableDisease.aspx.
34. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis. 2007;196(10):1459-64.
35. Uzicanin A, Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis. 2011;204 Suppl 1:S133-48.
36. Demicheli V, Jefferson T, Rivetti A, Price D. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2005;4:CD004407.
37. California Department of Public Health. Measles investigation quicksheet. California Department of Public Health. 2015. http://www.cdph.ca.gov/programs/immunize/Documents/CDPHMeaslesInvestigationQuicksheet.pdf.
38. Inman RL, Helson JC, Campbell JE. An approach to sensitivity analysis of computer models: part I-ranking of input variables, response surface validation, distribution effect and technique synopsis. J Qual Technol. 1981;13(4):174-83.
39. Inman RL, Helson JC, Campbell JE. An approach to sensitivity analysis of computer models: part II-ranking of input variables, response surface validation, distribution effect and technique synopsis. J Qual Technol. 1981;13(4):232-40.
40. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int Stat Rev. 1994;62(2):229-43.
41. Porco TC, Holbrook KA, Fernyak SE, Portnoy DL, Reiter R, Aragón TJ. Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model. BMC Public Health. 2004;4(1):34.
42. Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proc R Soc London A. 1927;115:700-21.
43. Wallinga J, Heijne JCM, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Med. 2005;2(11), e316.
44. Keeling MJ, Grenfell BT. Understanding the persistence of measles: reconciling theory, simulation and observation. Proc Biol Sci. 2002;269(1489):335-43.
45. Bolker B, Grenfell B. Space, persistence and dynamics of measles epidemics. Philos Trans R Soc Lond B Biol Sci. 1995;348(1325):309-20.
46. Keeling MJ. Modelling the persistence of measles. Trends Microbiol. 1997;5(12):513-8.
47. Bartlett MS. The critical community size for measles in the United States. J R Stat Soc. 1960;123(1):37-44.
48. Black FL. Measles endemicity in insular populations: critical community size and its evolutionary implication. J Theor Biol. 1966;11(2):207-11.
49. Keeling MJ, Grenfell BT. Disease extinction and community size: modeling the persistence of measles. Science. 1997;275(5296):65-7.
50. Black FL. The role of herd immunity in control of measles. Yale J Biol Med. 1982;55(3-4):351-60.
51. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. 1993;15(2):265-302.
52. Kiss IZ, Green DM. Comment on "properties of highly clustered networks". Phys Rev E Stat Nonlin Soft Matter Phys. 2008;78(4 Pt 2):048101.
53. Miller JC. Spread of infectious disease through clustered populations. J R Soc Interface. 2009;6(41):1121-34.
54. House T. Exact epidemic dynamics for generally clustered, complex networks. 2010. http://arxiv.org/abs/1006.3483.
55. Salathé M, Jones JH. Dynamics and control of diseases in networks with community structure. PLoS Comput Biol. 2010;6(4), e1000736.
56. Eames KTD, Keeling MJ. Contact tracing and disease control. Proc Biol Sci. 2003;270(1533):2565-71.
57. Eames KTD. Contact tracing strategies in heterogeneous populations. Epidemiol Infect. 2007;135(3):443-54.
58. House T, Keeling MJ. The impact of contact tracing in clustered populations. PLoS Comput Biol. 2010;6(3), e1000721.
59. Dallaire F, Serres GD, Tremblay F-W, Markowski F, Tipples G. Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons. J Infect Dis. 2009;200(10):1602-5.
60. Ordman CW, Jennings CG, Janeway CA. Chemical, clinical, and immunological studies on the products of human plasma fractionation. xii. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. J Clin Invest. 1944;23(4):541-9.
61. Stokes J, Maris EP, Gellis SS. Chemical, clinical, and immunological studies on the products of human plasma fractionation. xi. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles. J Clin Invest. 1944;23(4):531-40.
62. Young MK, Nimmo GR, Cripps AW, Jones MA. Post-exposure passive immunisation for preventing measles. Cochrane Database of Systematic Reviews 2014(4):CD010056.